Navigation Links
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
Date:5/14/2009

al. "Clinical Course of Patients with Non -Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib." Clin. Cancer Res, 12, 839-844(2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/3/839. Accessed on 5 May 2009.
  • Balak, M. N. et al. "Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors." Clin. Cancer Res. 12, 6494-6500 (2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/21/6494. Accessed on 5 May 2009.
  • Ledermann, J. A. "A randomised Phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 followign treatment of relapsed ovarian cancer (OC)." Oral presentation, Clinical Science Symposium. Monday, 1 June 2009, Session Time 9:45AM - 11:15AM. # 5501
  • Hilberg F. et al. "BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy." European Journal of Cancer Supplements. 2004; 2:50.
  • Lewis J. Kleinsmith. "Understanding Cancer and Related Topics: Understanding Angiogenesis." Rockville: National Cancer Institute, 2006. Available at: http://cancer.gov/cancertopics/understandingcancer. Accessed on 5 May 2009.
  • P Bo
    '/>"/>

  • SOURCE Boehringer Ingelheim
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
    2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
    3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
    8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
    9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
    10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
    11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- MHG ... provider, has launched its Medical Equipment and ...  These services are tailored to the cruise industry,s ... prompted industry operators to propose that they should ... Medical,s new program is intended to create standardized ...
    (Date:7/29/2014)... July 29, 2014 According to ... "Orthopedic Trauma Fixation Devices Market - Global Forecast, Market ... the global orthopedic trauma fixation devices market is estimated ... to grow at a CAGR of 7.2% from 2014 ... 9.3 billion in 2020. Browse the Orthopedic ...
    (Date:7/29/2014)... LAKE CITY and ... -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an ... in the development of improved novel formulations ... active molecules announces expansion of its pharmaceutical ... new development direction includes large molecule drugs that ...
    Breaking Medicine Technology:MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4
    ... 13, 2011 CVS Caremark Corporation (NYSE: ... president and chief financial officer of CVS Caremark, will ... 2011 Global Consumer Conference on June 22, 2011. Mr. ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO ) An ...
    ... 13, 2011 AmbiCom Holdings, Inc. (OTCQB: ABHI), a ... equipment suppliers, today announced that it has signed an ... Technology, Inc. ("ATI") subsidiary and E-Care Technology Corporation, ("ECT") ... runs for a period of three years. ...
    Cached Medicine Technology:CVS Caremark to Present at the Jefferies 2011 Global Consumer Conference 2AmbiCom Forms Joint Alliance With E-Care Technology Corporation 2AmbiCom Forms Joint Alliance With E-Care Technology Corporation 3
    (Date:7/29/2014)... Randy Dotinga ... News) -- When most children take on a task, ... of this neuro-boosting activity in kids with autism, according ... more severe symptoms of autism displayed even less of ... ,"This reduced flexibility often causes difficulty when children with ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 The Board of ... Holland & Hart LLP ’s Connie Akridge to ... currently serves as President of the Foundation. Akridge served as ... Akridge is a partner at Holland & Hart in Las ... and regulatory/administrative matters to insurance and healthcare clients for more ...
    (Date:7/29/2014)... Washington D.C. (PRWEB) July 29, 2014 ... spending in Medicare Part D by a projected $2.9 ... report by the actuarial firm Milliman released today by ... average Part D premiums could increase by as much ... high-priced hepatitis C drugs, including Sovaldi and Olysio. , ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 The Law Offices ... Stepping Stones of Hope, a non-profit organization providing grief camps ... hand the anguish and suffering our clients experience from the ... desire to support an organization like Stepping Stones of Hope, ... grief. , Stepping Stones of Hope also includes a monthly ...
    (Date:7/29/2014)... record the severity and regularity of their pain is ... , A new approach to the treatment of headaches, ... and is being led by Professor Paul Martin from ... He has developed an approach designed to enable people ... Learning to Cope with Triggers (LCT). , Using a ...
    Breaking Medicine News(10 mins):Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2
    ... Nov. 2 The National Alliance of Wound Care ... organization, announced today, the launch of their wound care ... newly redesigned website at, www.nawccb.org ... support our nearly 8000 certified wound care professionals with ...
    ... ... manufacturer of custom printer solutions, is expanding operations in the U.S. Martel provides custom ... and retail point of sale equipment. Martel,s customers in the U.S. include Abbott Laboratories. ... (PRWEB) November ...
    ... ... 2010 is for healthcare providers as a no-surgery and no-device alternative for sleep apnea ... with surgery and CPAP or any oral devices. , ... Hanover Park, IL (PRWEB) November 2, 2009 -- ...
    ... STANDUP FOR KIDS has been chosen by STAR OF ... are being asked to join forces for charity ... November,s National Homeless Youth Awareness Month. Local business owners ... THE NEIGHBORHOOD, are displaying posters and encouraging their customers to ...
    ... Polymer Group, Inc. (OTC Bulletin Board: POLGA; POLGB) (PGI) ... acquire the Barcelona, Spain-based Tesalca-Texnovo nonwovens businesses from Grupo ... expected to close by the end of November, subject ... http://www.newscom.com/cgi-bin/prnh/20080903/CLW036LOGO-b ) , In conjunction with the ...
    ... BOSTON, Nov. 1 Schering-Plough Corporation (NYSE: SGP ... therapy with boceprevir combination therapy in patients with chronic ... analyses were presented at the American Association for the ... Oct. 30-Nov. 3. , Boceprevir is an ...
    Cached Medicine News:Health News:National Alliance of Wound Care(R) Launches On-line Job Resource Center and New Website 2Health News:Martel Instruments Expands Its Custom Printer Solutions Business in North America; Liz Peirce Named Director of North American Business Development 2Health News:SleepApneaUSA.net Announced New 2010 ZHT (Zhou's Hypoxicology Therapy) Certification Class For Sleep Apnea As A No-Surgery And No-Device Alternative 2Health News:SleepApneaUSA.net Announced New 2010 ZHT (Zhou's Hypoxicology Therapy) Certification Class For Sleep Apnea As A No-Surgery And No-Device Alternative 3Health News:SleepApneaUSA.net Announced New 2010 ZHT (Zhou's Hypoxicology Therapy) Certification Class For Sleep Apnea As A No-Surgery And No-Device Alternative 4Health News:Local Businesses Unite, Calling an End to Youth Homelessness 2Health News:PGI Signs Agreement to Acquire Spanish Nonwovens Business Tesalca-Texnovo 2Health News:PGI Signs Agreement to Acquire Spanish Nonwovens Business Tesalca-Texnovo 3Health News:PGI Signs Agreement to Acquire Spanish Nonwovens Business Tesalca-Texnovo 4Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 3Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 4Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 5Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 6Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 7Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 8Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 10Health News:Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 11
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    20 GA TITANIUM RETINAL FORCEPS...
    Medicine Products: